(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 230.41%67.69K | 61.16%-293.11K | 45.40%-813.53K | 113.06%186.57K | -119.78%-193.49K | 93.55%-51.9K | 56.90%-754.7K | -176.95%-1.49M | -93.95%87.57K | 309.15%978K |
Net income from continuing operations | 28.81%-498.3K | -147.38%-449.62K | 38.20%-5.26M | -131.46%-3.63M | -773.18%-749.8K | 86.06%-699.91K | 91.06%-181.75K | -1,165.00%-8.51M | 56.61%-1.57M | 112.21%111.38K |
Operating gains losses | -111.07%-173.26K | 432.96%315.34K | -22.55%4.38M | -28.87%2.49M | 252.28%420.02K | 27.30%1.56M | -111.76%-94.71K | 270.32%5.66M | 394.47%3.5M | 124.51%119.23K |
Asset impairment expenditure | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --403.47K | --274.59K | --0 |
Unrealized gains and losses of investment securities | 143.19%443.95K | -161.81%-38.2K | -97.74%34.67K | 132.57%831.71K | 144.72%169.18K | -129.63%-1.03M | -93.79%61.8K | 39.32%1.53M | -159.79%-2.55M | -133.67%-378.3K |
Remuneration paid in stock | -55.08%7.12K | -75.65%7.12K | -35.34%83.01K | -76.41%16.6K | 251.14%21.35K | -29.81%15.84K | -0.45%29.22K | -21.27%128.37K | 147.32%70.38K | -79.29%6.08K |
Other non cashItems | 54.37%368.83K | 72.65%-178.42K | 54.87%-46.31K | 33.37%387.04K | -102.32%-19.93K | 2,472.45%238.93K | 47.52%-652.34K | -105.14%-102.61K | -80.84%290.19K | 41.98%860.22K |
Change In working capital | 43.77%-80.65K | -38.99%50.69K | 98.91%-6.51K | 25.42%88.14K | -113.22%-34.3K | 76.98%-143.43K | 127.23%83.08K | -149.88%-598.47K | -83.92%70.27K | 313.73%259.39K |
-Change in receivables | 640.86%17.94K | -70.11%16.58K | 110.75%15.46K | 855.89%16.69K | -124.67%-53.37K | 92.90%-3.32K | 117.81%55.46K | -115.65%-143.83K | -101.86%-2.21K | 291.07%216.38K |
-Change in payables and accrued expense | 29.64%-98.59K | 23.50%34.12K | 64.56%-21.97K | -84.64%71.45K | 105.45%19.07K | 23.73%-140.11K | 344.40%27.62K | 44.64%-61.99K | 559.57%465.13K | -128.53%-349.64K |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-392.65K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 230.41%67.69K | 61.16%-293.11K | 45.40%-813.53K | 113.06%186.57K | -119.78%-193.49K | 93.55%-51.9K | 56.90%-754.7K | -176.95%-1.49M | -93.95%87.57K | 309.15%978K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Cash from discontinued financing activities | ||||||||||
Net cash flow | ||||||||||
Beginning cash position | -49.25%362.6K | -55.37%655.7K | -50.35%1.47M | -66.05%469.13K | 64.16%662.63K | -40.85%714.53K | -50.35%1.47M | 189.27%2.96M | -8.57%1.38M | -68.27%403.66K |
Current changes in cash | 230.41%67.69K | 61.16%-293.11K | 45.40%-813.53K | 113.06%186.57K | -119.78%-193.49K | 93.55%-51.9K | 56.90%-754.7K | -176.95%-1.49M | -93.95%87.57K | 309.15%978K |
End cash Position | -35.06%430.28K | -49.25%362.6K | -55.37%655.7K | -55.37%655.7K | -66.05%469.13K | 64.16%662.63K | -40.85%714.53K | -50.35%1.47M | -50.35%1.47M | -8.57%1.38M |
Free cash from | 230.41%67.69K | 61.16%-293.11K | 45.40%-813.53K | 113.06%186.57K | -119.78%-193.49K | 93.55%-51.9K | 56.90%-754.7K | -176.95%-1.49M | -93.95%87.57K | 309.15%978K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data